| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |